Elder Pharmaceuticals in association with Spain-based drug firm Ferrer has unveiled -- Zalain -- a medicine used to treat fungal skin infections, in India. The company has launched the same to strengthen its anti-infectives division which stood at about Rs 113.61 crore in FY 2012
The company, to strengthen position in the segment in domestic market, has also lined-up five more launches of nutraceutical products in India in partnerships with international firms in the coming six months.
At present, the company markets various nutraceutical products in the country, including calcium supplement -- Shelcal. Its product portfolio comprises licensed as well as own brands.
Elder Pharmaceuticals posted 15.46% fall in its consolidated net profit at Rs 14.60 crore for the quarter ended March 31, 2012 as compared to Rs 17.27 crore in the corresponding period of previous fiscal. The fall is mainly on account of reduction in material costs.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: